The list of vulnerable persons presenting a risk of developing a serious form of infection with the SARS-CoV-2 virus :

1. Persons aged 65 years and above (although patients aged between 50 – 70 should be monitored more closely);
2. Persons with a cardiovascular history (ATCD): complicated arterial hypertension (with cardiac, renal and vascular-cerebral complications), cerebrovascular accident or coronary artery disease, cardiac surgery, heart failure stage NYHA III or IV;
3. Persons with uncontrolled diabetes or with complications;
4. Persons with a chronic respiratory pathology likely to decompensate in the event of a viral infection: obstructive bronchopneumopathy, severe asthma, pulmonary fibrosis, sleep apnea syndrome, cystic fibrosis;
5. Persons with chronic renal insufficiency on dialysis;
6. Persons with progressive cancer under treatment (excluding hormone therapy);
7. Persons who are obese with a body mass index (BMI) > 30 kgm2;
8. Persons with congenital or acquired immunosuppression:
   • cancer chemotherapy,
   • immunosuppressive therapy,
   • biotherapy and/or corticosteroid therapy at immunosuppressive doses;
   • uncontrolled HIV infection or infection with CD4 < 200/mm3 ;
9. Persons following solid organ or hematopoietic stem cell transplant; related to a malignant hemopathy during treatment;
10. Persons with stage B cirrhosis of at least Child Pugh’s score;
11. Persons with a major sickle cell syndrome or a history of splenectomy;
12. Women in the third trimester of pregnancy.